Linden Advisors »

Alnylam Pharmaceuticals shares owned by Linden Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Linden Advisors from 13F filings

Historical chart of Linden Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Linden Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Linden Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.5M 14k 456.00